Long-term persistence of a polyclonal T cell repertoire after gene therapy for X-linked severe combined immunodeficiency.
about
Recent Advances in Lentiviral Vaccines for HIV-1 InfectionUse of V(D)J recombination excision circles to identify T- and B-cell defects and to monitor the treatment in primary and acquired immunodeficienciesHematopoietic stem cell gene therapy:assessing the relevance of preclinical modelsGene therapy for primary immunodeficienciesRetroviral integrations in gene therapy trialsHematopoietic stem cell engineering at a crossroadsGene therapy on the moveCurrent translational and clinical practices in hematopoietic cell and gene therapyGene therapy studies in a canine model of X-linked severe combined immunodeficiencyApplications of CRISPR/Cas9 for Gene Editing in Hereditary Movement DisordersTherapeutic genome editing: prospects and challengesDevelopment and utility of an internal threshold control (ITC) real-time PCR assay for exogenous DNA detectionGene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand?Gene therapy for PIDs: progress, pitfalls and prospectsConcise review: lessons learned from clinical trials of gene therapy in monogenic immunodeficiency diseases.Toward Personalized Gene Therapy: Characterizing the Host Genetic Control of Lentiviral-Vector-Mediated Hepatic Gene Delivery.Single Cell-Based Vector Tracing in Patients with ADA-SCID Treated with Stem Cell Gene Therapy.T-cell Receptor and K-deleting Recombination Excision Circles in Newborn Screening of T- and B-cell Defects: Review of the Literature and Future Challenges.HSV-sr39TK positron emission tomography and suicide gene elimination of human hematopoietic stem cells and their progeny in humanized mice.Impact of next-generation sequencing error on analysis of barcoded plasmid libraries of known complexity and sequence.IL-7 in human health and disease.Pretransplant mobilization with granulocyte colony-stimulating factor improves B-cell reconstitution by lentiviral vector gene therapy in SCID-X1 mice.Thymidine kinase suicide gene-mediated ganciclovir ablation of autologous gene-modified rhesus hematopoiesis.The human application of gene therapy to re-program T-cell specificity using chimeric antigen receptorsLentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome.Mouse transplant models for evaluating the oncogenic risk of a self-inactivating XSCID lentiviral vectorA modified γ-retrovirus vector for X-linked severe combined immunodeficiency.Clinical applications of gene therapy for primary immunodeficiencies.History and current status of newborn screening for severe combined immunodeficiency.The long quest for neonatal screening for severe combined immunodeficiency.Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans.Post-transplantation B cell function in different molecular types of SCIDQuantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation.Evaluating risks of insertional mutagenesis by DNA transposons in gene therapy.Gene therapy researchers' assessments of risks and perceptions of risk acceptability in clinical trials.A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation.Transduction of human CD34+ repopulating cells with a self-inactivating lentiviral vector for SCID-X1 produced at clinical scale by a stable cell line.Rapid and Efficient Stable Gene Transfer to Mesenchymal Stromal Cells Using a Modified Foamy Virus Vector.Effect of fetal bovine serum on foamy and lentiviral vector production.Induced pluripotent stem cells in clinical hematology: potentials, progress, and remaining obstacles.
P2860
Q26742169-9AA8BB6E-AFDD-4E87-B972-40EE42AC5F77Q26827084-16E3E896-1FBD-4E7F-BF76-A75DF286462DQ26859147-809A9107-71F1-4F40-9A45-4FA273E2FEDFQ26864856-28B8DD44-12FE-4D87-A85F-520DB7EF9DE9Q26991660-D7A84CFE-8EE0-4FE1-A5ED-DD3AC73D34DEQ27001570-3A575924-2FF7-40F5-BA54-7599EB198895Q27007012-0B1C3058-59D3-4A45-8D02-F199E6E2A346Q27024456-2B37DBDD-805F-43FB-BF0B-BD5538F06063Q27026069-02AF586B-E68A-4007-B04F-6D031A52A320Q28076197-F1F0037C-44B7-4FCB-95F5-B0E4327A1162Q28087380-02A4AEC8-CEF0-4C31-8166-C5A9054721BAQ28730144-7674DBAA-DB9D-4C84-BF29-AFE9ABE7F998Q30364488-90FB823F-5BF3-4095-A332-8608E305A918Q33406944-E84BDB0A-3D11-4636-857F-26DEE2FDF179Q33552027-0DB8E7B4-DE23-436F-BB89-D33B16B6F09EQ33633293-E8389F8B-74DA-4FC2-9B80-81B9E937748CQ33784306-8B690376-53C9-4194-91B2-158EA0AD8D50Q34074060-84704F8B-0B08-4E0A-A080-C0F298012DA7Q34204696-ADA363CC-10D6-458F-8FD6-A19580CD4D3DQ34249667-7508450F-C527-405D-93DD-A882B1B6D684Q34260682-C2CBC5F4-E2DC-4AFB-B3B2-030DC72993FFQ34268121-0C0AC051-9A24-4354-8206-84E15A434489Q34295186-56E5DA67-A6A9-4C05-ABF2-42DAB8FE0500Q34309388-62D739EA-C473-46B8-9019-B579510DE2E6Q34356904-23D89EC5-C82F-4DFA-ACC5-80929CF023ACQ34692989-9EA5D8BA-5DC3-4347-8A78-5631EDF597C0Q34763502-CC57A2E3-A2BE-451B-96C6-A5EAAF2BB4E2Q35539617-81C86C2B-9838-4D3E-ACE4-E3F5BD71B7D8Q35613205-1DFA435F-23D6-4209-B5A4-47F6EE9E3A20Q35803435-E99E9C07-3899-4A57-9A81-4981E24E11ACQ36370817-CFF1112B-EE95-445A-814B-13D348E0E20FQ36546267-96787D43-EDAE-4905-8C35-CFA6ED8BC6C4Q36674480-996BD2E0-20C0-4AA5-A242-6A35DF4272E4Q36698269-DCF90CB3-5874-44D2-B798-1B1F3D6E6057Q36740288-2548297A-22B5-4A8F-A4E9-4F8D7315E576Q36870401-1C772052-E297-4BB4-82AC-C849265A05F2Q37066362-D2361B91-990F-43A9-81CB-B4F3E2A2EB07Q37170654-C311AFDB-081B-47BC-877B-0E5BEF2DF331Q37233537-47B249EC-3AE5-45A1-8CC3-D1270F3C0F22Q38007342-1AD82070-6412-446E-B7A6-C1E915B3DFB4
P2860
Long-term persistence of a polyclonal T cell repertoire after gene therapy for X-linked severe combined immunodeficiency.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Long-term persistence of a pol ...... ere combined immunodeficiency.
@en
Long-term persistence of a pol ...... ere combined immunodeficiency.
@nl
type
label
Long-term persistence of a pol ...... ere combined immunodeficiency.
@en
Long-term persistence of a pol ...... ere combined immunodeficiency.
@nl
prefLabel
Long-term persistence of a pol ...... ere combined immunodeficiency.
@en
Long-term persistence of a pol ...... ere combined immunodeficiency.
@nl
P2093
P2860
P1476
Long-term persistence of a pol ...... ere combined immunodeficiency.
@en
P2093
Abdulaziz Al Ghonaium
Christine Kinnon
E Graham Davies
H Bobby Gaspar
Jinhua Bayford
Kathryn L Parsley
Lucinda Brown
Samantha Cooray
Steven J Howe
Stuart Adams
P2860
P304
P356
10.1126/SCITRANSLMED.3002715
P407
P577
2011-08-01T00:00:00Z